Corline Biomedical AB (OSTO:CLBIO) FFO


OSTO:CLBIO Corline Biomedical AB OSTO:CLBIO
43 GF Score
Price kr17.75
GF Value kr4.94
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Corline Biomedical AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:CLBIO
43GF Score
Corline Biomedical AB OSTO:CLBIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Corline Biomedical AB (OSTO:CLBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of kr17.75 is trading 259.3% above its estimated GF Value™ of kr4.94. GuruFocus considers Corline Biomedical AB to be Significantly Overvalued.

Key valuation signals for OSTO:CLBIO:

  • FFO:
  • GF Value™: kr4.94 vs. price of kr17.75 (259.3% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the OSTO:CLBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Corline Biomedical AB Business Description

Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for OSTO:CLBIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.75
Price
kr4.94
GF Value